LOWE
Product · Developer tool by Recursion
Proprietary drug discovery software for navigating biological and chemical complexity.
LOWE is Recursion's proprietary drug discovery software that provides a scientist-facing interface for the Recursion Operating System. It enables researchers to explore biological maps, identify therapeutic targets, and design optimized molecules within a unified digital and physical workflow.
- Launched
- 2024-01-08
Category: Drug Discovery
- Unveiled at the 2024 J.P. Morgan Healthcare Conference
- Primary interface for the Recursion Operating System
- Supports target discovery and precision drug design
- Bridges digital analysis and physical lab automation
Overview
LOWE is a proprietary drug discovery software tool developed by Recursion to empower scientists in navigating the complexities of biology and chemistry. Unveiled in early 2024, the software serves as a primary interface for interacting with the Recursion Operating System and its extensive biological maps. It allows researchers to leverage AI-driven insights to identify novel therapeutic targets and design optimized molecules more efficiently. LOWE is designed to bridge the gap between digital analysis and physical lab automation, providing a unified workspace for the discovery process. The tool is used internally and has been provided to select partners to advance their drug discovery programs.
Drug Discovery Capabilities
- Recursion OS Interface: The software serves as a primary interface for scientists to interact with the Recursion Operating System and its biological maps.
- Target Discovery Exploration: LOWE enables the exploration of complex biological relationships to identify novel therapeutic targets.
- Precision Drug Design: The tool supports the design and optimization of chemical compounds within an integrated digital environment.
Use cases
- Scientists use the interface to interact with the Recursion OS and its vast biological maps for target identification.
- Researchers explore complex biological relationships to discover novel therapeutic targets for various diseases.
- Drug developers design and optimize chemical compounds within an integrated digital and physical lab environment.
Added by AntSpace from public sources (recursion.com).